Carboquone combined with methotrexate and 5-fluorouracil for recurrent and advanced ovarian cancer. 1993

J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002225 Carbazilquinone An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients. Carboquinone,Carboquone,Esquinon
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
March 1985, Gynecologic oncology,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
January 2006, Anticancer research,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
September 1980, Canadian Medical Association journal,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
May 1987, Gynecologic oncology,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
March 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
September 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
January 1991, Oncology,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
April 1975, Cancer,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
March 1986, Gynecologic oncology,
J U Mäenpää, and E Heinonen, and P Karnani, and A Kauppila, and T Kuoppala, and T Salmi, and P Sipilä, and U Nieminen
June 2003, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!